Golisano Children's Hospital at Strong

"Research is a vital part of the daily activity at Golisano Children's Hospital."

One of the top 20 Pediatric Research Programs in the United States, Second for NIH Funding in New York State

Numbers tell part of the story of research at Golisano Children's Hospital. More than $22 million in grant money now funds research at the hospital, which is second in New York State in National Institutes of Health funding. Twenty-one physicians at the Golisano Children's Hospital have at least one grant of $100,000 or more for research.

From Basic Science and Clinical Research to State-of-the-Art Treatments

"Research is a vital part of the daily activity at Golisano Children's Hospital," says George Schwartz, M.D., director, Strong Children's Research Center. The well-known Haemophilus influenzae type b (Hib) vaccine was developed and tested at Golisano Children's Hospital. This vaccine has reduced the incidence of life-threatening illnesses caused by Hib to near zero. From bench research to clinical trials, clinical studies, and health services research, Golisano Children's Hospital has a long history of bringing safer, more effective drugs and treatments to the pediatric population. Coordinated under the auspices of the Children's Research Center, the Hospital's research activities are enriched by its affiliation with the University of Rochester (UR) School of Medicine and Dentistry, the UR School of Nursing, and the Aab Institute.

Promising New Investigations are Underway

Current research is far-ranging. Among the many initiatives underway at Golisano Children's Hospital:

An investigation into the mechanism and prevention of lung damage resulting from the organism Pneumocystis carinii.

A study within Hematology / Oncology of how red blood cells are formed in the embryo and later in development.

An examination of the physiology of lung damage during conditions such as bronchopulmonary dysplasia, oxygen toxicity, and environmental pollutants.

Research to gain a better understanding of how the normal kidney adapts to metabolic acidosis and what goes wrong in renal tubular acidosis.

Through the National Children's Oncology Group, testing of specific therapies for various forms of pediatric cancer.

A lead role in a nationally sponsored pediatric AIDS clinical trial.

Monitoring long-term outcomes resulting from pediatric cardiomyopathy or from the treatment of childhood leukemias with cardio-toxic agents.

Research to improve the delivery of immunizations and health care to the poor, to end smoking in teenagers, to manage asthma in early childhood, to integrate telemedicine and home nursing in the care of children away from the hospital, and to measure the impact of New York's Child Health and Improvement Program.